International Diversity of its Authorship
All contributing authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Sufficient participation in the work is of utmost importance:
Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically for important intellectual content, must have read and approved the final version of the manuscript and approve of its submission to this journal.
Criteria for Authorship
Everyone who has made substantial intellectual contributions to the study on which the article is based (for example, to the research question, design, analysis, interpretation, and written description) should be an author. Only an individual who has made substantial intellectual contributions should be an author. Performing technical services, translating text, identifying patients for study, supplying materials, and providing funding or administrative oversight over facilities where the work was done are not, in themselves, sufficient for authorship, although these contributions may be acknowledged in the manuscript. One author (a “guarantor”) should take responsibility for the integrity of the work as a whole. Often this is the corresponding author, the one who sends in the manuscript and receives reviews, but other authors can have this role. All authors should approve the final version of the manuscript. It is preferable that all authors be familiar with all aspects of the work.
Number of Authors
Editors should not arbitrarily limit the number of authors. There are legitimate reasons for multiple authors in some kinds of research, such as multi-centre, randomized controlled trials. In these situations, a subset of authors may be listed with the title, with the notation that they have prepared the manuscript on behalf of all contributors. If editors believe the number of authors is unusually large, relative to the scope and complexity of the work, they can ask for a detailed description of each author’s contributions to the work. If some do not meet criteria for authorship, editors can require that their names be removed as a condition of publication.
Order of Authorship
The authors themselves should decide the order in which authors are listed in an article. No one else knows as well as they do their respective contributions and the agreements they have made among themselves.
Changes to Authorship
For all submission to CFILE, authorship change request should be submitted to Editorial Office of CFILE through Corresponding author. Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Editor from the corresponding author of the accepted manuscript and must include: a) the reason the name should be added or removed, or the author names rearranged and b) signed CFILE Change of Authorship Form <https://www.cifilejournal.com/page_1404.html> by all authors that they agree with the addition, removal or rearrangement. The corresponding author should certify that all authors meet the Committee on Publication Ethics (COPE) authorship standards and that all authors consent to the change. All authors will be asked to sign an authorship statement after the manuscript has been accepted. By signing the change of authorship form, any authors who have been added, removed, or reordered indicate that they agree to the changes. Until the editorial office gets the completed form, the relevant submission will be kept on hold for further processing. No authorship change is allowed after publication of manuscript.
The CFILE is made available to the public under the open access policy. CFILE will ask all authors of the acceptance article to sign a Copyright Agreement Form (https://www.cifilejournal.com/page_1404.html) for granting the necessary publishing rights once the manuscript has been accepted. The corresponding author can sign the copyright form on behalf of co-authors if she/he has holded permission to sign on behalf of co-authors. The accepted manuscript is moved into production after the copyright transfer form from the relevant author of the manuscript is received. Because the author(s) publish their manuscript as open access, the author(s) retain(s) ownership of the copyright for their content, such as patents, trademarks, and designs. The conditions of the Creative Commons Attribution 4.0 International License are incorporated into the author(s) contract, dictating what others can do with the author(s) manuscript after it is published. Furthermore, after being properly attributed, the Creative Commons Attribution 4.0 International License allows for unrestricted use, distribution, modification, and reproduction in any medium.
Reversion of Author Rights
Author(s) are advised to consider how the author(s) will utilize their work in the future and to keep certain rights (apart from rights towards patent, trademark and design) to achieve their academic and professional objectives. Right of reversion Articles may be accepted for publication but then rejected during the publishing process, even after being publicly posted in "Articles in Press" form, in which case all rights revert to the author. An author or authors’ employer or institution retains certain rights by signing the authorship form: https://www.cifilejournal.com/page_1404.html
Authors may want to retain rights to do the following:
- Make instructional versions of the work, such as class notes, study aids, or electronic reserves.
- Use a portion of the work as the foundation for a future publication
- For a future publication, use a different or expanded version of the work.
- Use the work in derivative works in the future, such as a dissertation or thesis.
CFILE Publisher provides access to archived material through CFILE archives. Manuscripts are the parts of an open archive, which are made freely available from CFILE website. All articles published open access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by Creative Commons user license called "Creative Common Attribution". The CFILE and the end users have non-exclusive rights under Creative Commons Attribution License (CC-BY). Any supporting information along with the contribution of authors in all subsequent version for publication in CFILE, the CFILE is granted a perpetual, non-exclusive license to publish, transfer, distribute as a whole or part of the information throughout the world in all languages. The corresponding author authorized the co-authors to enter into Copyright Agreement Form. The corresponding author and co-authors guarantees that the submitted manuscript is original, has not been submitted to any other journals, has not been published previously, and does not infringe on other person’ rights (including without limitation copyrights, patent rights and the trademark right). All authors further guarantees that the contribution does not contain any libelous statement, facts, instructions that can cause damage and injury to third parties and disclosure of any secret or confidential information. For open access articles the publisher uses an exclusive licensing agreement in which authors retain copyright in their manuscript.
USER LICENSE AGREEMENT
The CFILE Journal provides access to archived material through CFILE archives. All articles published open access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by Creative Commons user license called "Creative Common Attribution" (https://creativecommons.org/licenses/by/4.0/).
Conflict of Interest
Authors are requested to evident whether impending conflicts do or do not exist by signing conflict of interest disclosure form. CFILE will ask all authors of the acceptance article to sign a Copyright Agreement Form: https://www.cifilejournal.com/page_1404.html. The corresponding author can sign the conflict of Interest form on behalf of co-authors if she/he has holded permission to sign on behalf of co-authors. Therefore the 2 signed Copyrights and Conflict of Interest forms must be archived in the Journal Editorial Office for each accepted article.
Responsibilities on Conflicts of Interest
Public trust in the scientific process and the credibility of published articles depend in part on how transparently conflicts of interest are handled during the planning, implementation, writing, peer review, editing, and publication of scientific work. Financial relationships (such as employment, consultancies, stock ownership or options, honoraria, patents, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships or rivalries, academic competition, and intellectual beliefs. All authors should comply with the journals’ policies on conflict of interest. All participants in the peer-review and publication process, not only authors but also peer reviewers, editors, and editorial board members of journals must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all relationships that could be viewed as potential conflicts of interest.
- Authors: When authors submit a manuscript of any type or format they are responsible for disclosing all financial and personal relationships that might bias or be seen to bias their work by signing conflict of interest disclosure form.
- Reviewers: Reviewers should be asked at the time they are asked to critique a manuscript if they have conflicts of interest that could complicate their review. Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests.
- Editors: Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff. Guest editors should follow these same procedures.
Reporting Conflicts of Interest
Articles should be published with statements or supporting documents, such as the CFILE conflict of interest form, declaring:
- Authors’ conflicts of interest; and
- Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication; or a statement declaring that the supporting source had no such involvement; and
- Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is on-going.
To support the above statements, editors may request that authors of a study sponsored by a funder with a proprietary or financial interest in the outcome sign a statement, such as “I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis.”